Free Trial
→ Read now. Do not delete. You’ve been warned. (From Porter & Company) (Ad)tc pixel Free CGEM Stock Alerts

Cullinan Therapeutics (CGEM) Short Interest Ratio & Short Volume

Cullinan Therapeutics logo
$15.52 +0.06 (+0.39%)
Closing price 05/27/2026 04:00 PM Eastern
Extended Trading
$15.48 -0.04 (-0.26%)
As of 04:05 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Cullinan Therapeutics Short Interest Overview

As of May 15, 2026, Cullinan Therapeutics (CGEM) had a short interest of 8.68 million shares sold short, representing 15.45% of the public float. This marks a -1.35% decrease in short interest since the prior report. The short interest ratio (days to cover) is 8.2, meaning it would take 8.2 days of the average trading volume of 956,542 shares to cover all short positions.

Current Short Interest
8,680,186 shares
Previous Short Interest
8,799,071 shares
Change Vs. Previous Month
-1.35%
Dollar Volume Sold Short
$136.54 million
Short Interest Ratio
8.2 Days to Cover
Last Record Date
May 15, 2026
Outstanding Shares
61,460,000 shares
Short Percent of Float
15.45%
Today's Trading Volume
1,344,194 shares
Average Trading Volume
956,542 shares
Today's Volume Vs. Average
141%
Short Selling Cullinan Therapeutics?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Cullinan Therapeutics and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

CGEM Short Interest Over Time

CGEM Days to Cover Over Time

CGEM Percentage of Float Shorted Over Time

Cullinan Therapeutics Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/15/20268,680,186 shares $136.54 million -1.4%15.5%8.19 $15.73
4/30/20268,799,071 shares $114.83 million +8.4%15.7%15.27 $13.05
11/14/20256,678,836 shares $57.10 million +2.6%12.0%9.63 $8.55
10/31/20256,509,523 shares $56.37 million -1.8%11.7%6 $8.66
10/15/20256,630,000 shares $57.22 million +8.7%18.0%8.1 $8.63
9/30/20256,100,000 shares $36.17 million -1.3%16.8%9.6 $5.93
9/15/20256,180,000 shares $39.24 million -1.0%17.0%14 $6.35
8/31/20256,240,000 shares $47.05 million +6.7%17.2%16.1 $7.54
8/15/20255,850,000 shares $44.81 million -9.3%16.1%16.6 $7.66
7/31/20256,450,000 shares $50.12 million +9.7%17.8%17.6 $7.77
7/15/20255,880,000 shares $43.81 million -1.8%16.4%15.6 $7.45
6/30/20255,990,000 shares $45.10 million +0.5%16.7%14.1 $7.53
6/15/20255,960,000 shares $51.32 million -3.6%16.6%13.9 $8.61
5/31/20256,180,000 shares $53.52 million +3.2%17.2%13.7 $8.66
5/15/20255,990,000 shares $43.37 million -19.9%16.7%13 $7.24
4/30/20257,480,000 shares $61.93 million -6.4%20.9%16.2 $8.28
4/15/20257,990,000 shares $62.32 million -6.3%22.5%17.3 $7.80
3/31/20258,530,000 shares $64.57 million -1.6%24.1%18.1 $7.57
3/15/20258,670,000 shares $76.21 million +0.1%24.4%17.7 $8.79
2/28/20258,660,000 shares $73.52 million -1.3%24.4%17.4 $8.49
2/15/20258,770,000 shares $83.58 million +0.5%24.6%17.2 $9.53
1/31/20258,730,000 shares $92.19 million -10.7%23.7%15.7 $10.56
1/15/20259,780,000 shares $99.56 million -0.4%26.6%18.4 $10.18
12/31/20249,820,000 shares $119.61 million +1.8%26.7%19 $12.18
12/15/20249,650,000 shares $113.39 million +5.4%26.0%19.5 $11.75
11/30/20249,160,000 shares $123.20 million +5.2%24.7%16.8 $13.45
11/15/20248,710,000 shares $120.72 million -3.4%23.5%16.2 $13.86
10/31/20249,020,000 shares $140.26 million -0.4%23.0%17.1 $15.55
10/15/20249,060,000 shares $147.13 million -1.6%23.2%15.7 $16.24
9/30/20249,210,000 shares $154.18 million +9.4%23.6%14.2 $16.74
9/15/20248,420,000 shares $151.14 million +4.6%21.6%11.7 $17.95
8/31/20248,050,000 shares $157.78 million -1.4%20.9%10.2 $19.60
8/15/20248,160,000 shares $137.99 million -2.4%21.2%10.3 $16.91
7/31/20248,360,000 shares $161.77 million +6.0%20.6%10 $19.35
7/15/20247,890,000 shares $130.90 million +0.6%19.4%8 $16.59
6/30/20247,840,000 shares $136.73 million +73.5%19.3%8 $17.44
6/15/20244,520,000 shares $85.34 million +4.2%10.3%5.1 $18.88
5/31/20244,340,000 shares $101.99 million +16.0%11.0%5.5 $23.50
5/15/20243,740,000 shares $99.93 million +58.5%11.9%5 $26.72
4/30/20242,360,000 shares $63.74 million +40.5%10.2%3.3 $27.01
How to claim a stake in SpaceX before the June 12 IPO (Ad)

SpaceX is expected to go public on June 12 - and for the first time, everyday investors may have a way in before the IPO. Jeff Brown, who identified Bitcoin, Tesla, and Nvidia before gains as high as 52,400%, 2,150%, and 32,000% respectively, is sharing the details on how to claim a stake in Elon Musk's company before it hits public markets.tc pixel

See exactly how to position yourself in SpaceX before June 12
4/15/20241,680,000 shares $27.80 million +16.7%6.4%3.1 $16.55
3/31/20241,440,000 shares $24.54 million +53.9%5.5%3.4 $17.04
3/15/2024935,400 shares $14.90 million +34.8%3.6%2.3 $15.93
2/29/2024694,100 shares $12.82 million -11.5%2.6%1.8 $18.47
2/15/2024783,900 shares $14.45 million -46.7%2.9%2.3 $18.43
1/31/20241,470,000 shares $22.26 million +34.9%5.4%5.1 $15.14
1/15/20241,090,000 shares $11.54 million +3.8%4.0%5.2 $10.59
12/31/20231,050,000 shares $10.70 million -48.5%3.9%5.4 $10.19
12/15/20232,040,000 shares $16.81 million -3.3%7.5%11.1 $8.24
11/30/20232,110,000 shares $17.28 million -2.3%7.8%12.5 $8.19
11/15/20232,160,000 shares $19.16 million +0.5%8.0%13.3 $8.87
10/31/20232,150,000 shares $20.06 million -1.8%7.9%12.9 $9.33
10/15/20232,190,000 shares $19.27 million -0.5%8.1%12.9 $8.80
9/30/20232,200,000 shares $19.91 million +0.9%8.1%12.1 $9.05
9/15/20232,180,000 shares $21.71 million -17.7%8.0%11.5 $9.96
8/31/20232,650,000 shares $27.43 million +33.2%9.8%10.2 $10.35
8/15/20231,990,000 shares $20.32 million +2.6%7.4%6.4 $10.21
7/31/20231,940,000 shares $20.54 million -18.5%8.2%6.1 $10.59
7/15/20232,380,000 shares $27.89 million +15.5%10.1%7.6 $11.72
6/30/20232,060,000 shares $22.17 million -11.6%8.7%6.8 $10.76
6/15/20232,330,000 shares $29.59 million +2.6%9.9%7.6 $12.70
5/31/20232,270,000 shares $23.34 million +0.9%9.6%8.6 $10.28
5/15/20232,250,000 shares $22.37 million +0.5%9.5%10.7 $9.94
4/30/20232,240,000 shares $21.80 million +0.5%9.5%10.7 $9.73
4/15/20232,230,000 shares $22.34 million +0.5%9.5%9.9 $10.02
3/31/20232,220,000 shares $22.71 million +1.8%9.4%10.2 $10.23
3/15/20232,180,000 shares $24.44 million +3.8%7.7%10.5 $11.21
2/28/20232,100,000 shares $23.71 million +1.5%7.0%13.3 $11.29
2/15/20232,070,000 shares $23.91 million +6.7%6.9%13.7 $11.55
1/31/20231,940,000 shares $22.58 million -9.4%6.6%13.7 $11.64
1/15/20232,140,000 shares $23.50 million -1.8%7.2%16.4 $10.98
12/30/20222,180,000 shares $23.00 million No Change7.4%17 $10.55
12/15/20222,180,000 shares $24.96 million No Change7.4%15.9 $11.45
11/30/20222,180,000 shares $27.10 million -5.6%7.4%14.8 $12.43
11/15/20222,310,000 shares $29.48 million -4.9%8.0%14.2 $12.76
10/31/20222,430,000 shares $31.93 million -0.4%8.5%15.4 $13.14
10/15/20222,440,000 shares $30.79 million -1.2%8.5%15.7 $12.62
9/30/20222,470,000 shares $31.67 million +14.4%8.6%14.2 $12.82
9/15/20222,160,000 shares $28.21 million -13.6%7.5%10.9 $13.06
8/31/20222,500,000 shares $33.70 million No Change8.8%10.5 $13.48
8/15/20222,500,000 shares $35.40 million +2.9%8.8%8.5 $14.16
7/31/20222,430,000 shares $32.83 million -17.9%9.9%4.1 $13.51
7/15/20222,960,000 shares $43.57 million -1.7%12.1%4.9 $14.72
6/30/20223,010,000 shares $38.59 million -0.7%12.3%5.2 $12.82
6/15/20223,030,000 shares $36.09 million +6.3%12.4%5.2 $11.91
5/31/20222,850,000 shares $30.47 million +4.0%11.7%5.3 $10.69
5/15/20222,740,000 shares $29.10 million +3.8%11.2%5.7 $10.62
4/30/20222,640,000 shares $25.90 million +7.8%11.2%14.4 $9.81
4/15/20222,450,000 shares $27.44 million -3.5%10.4%13.2 $11.20
3/31/20222,540,000 shares $26.59 million -7.3%11.0%13.3 $10.47
Read now. Do not delete. You’ve been warned. (Ad)

Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” Porter Stansberry exposes how the convergence of three immense forces is about to rewrite everything about the American way of life: how you work, save, invest… it’s all about to change.tc pixel

Don’t be left behind. Click here now.
3/15/20222,740,000 shares $34.91 million +1.5%12.1%13.2 $12.74
2/28/20222,700,000 shares $38.72 million +5.9%12.0%10.3 $14.34
2/15/20222,550,000 shares $37.69 million -3.4%11.3%9.6 $14.78
1/31/20222,640,000 shares $35.59 million -13.7%12.1%9.9 $13.48
1/15/20223,060,000 shares $41.89 million -1.0%13.4%11.4 $13.69
12/31/20213,090,000 shares $47.68 million +27.2%14.3%10.7 $15.43
12/15/20212,430,000 shares $38.71 million +3.4%11.2%9.4 $15.93
11/30/20212,350,000 shares $42.30 million -0.8%10.9%9.9 $18.00
11/15/20212,370,000 shares $49.68 million -7.8%8.1%9.3 $20.96
10/29/20212,570,000 shares $57.11 million +0.8%8.9%10.3 $22.22
10/15/20212,550,000 shares $63.75 million -1.9%8.8%10.6 $25.00
9/30/20212,600,000 shares $58.68 million +42.9%9.0%11.7 $22.57
9/15/20211,820,000 shares $52.78 million -24.5%6.3%7.6 $29.00
8/31/20212,410,000 shares $68.01 million -11.1%8.4%11.7 $28.22
8/13/20212,710,000 shares $75.09 million No Change9.5%12.4 $27.71

CGEM Short Interest - Frequently Asked Questions

Short interest is the volume of Cullinan Therapeutics shares that have been sold short but have not yet been covered or closed out. As of May 15th, traders have sold 8,680,186 shares of CGEM short. 15.45% of Cullinan Therapeutics' shares are currently sold short. Learn More on Cullinan Therapeutics' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CGEM shares currently have a short interest ratio of 8.2. Learn More on Cullinan Therapeutics's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 15.45% of Cullinan Therapeutics' floating shares are currently sold short.

Cullinan Therapeutics saw a decrease in short interest in May. As of May 15th, there was short interest totaling 8,680,186 shares, a decrease of 1.4% from the previous total of 8,799,071 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

15.45% of Cullinan Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Cullinan Therapeutics: Edgewise Therapeutics, Inc. (12.53%), Viking Therapeutics, Inc. (20.26%), Erasca, Inc. (11.78%), Twist Bioscience Corporation (27.47%), Tango Therapeutics, Inc. (23.52%), Denali Therapeutics Inc. (10.10%), Arcus Biosciences, Inc. (9.57%), Beam Therapeutics Inc. (26.79%), Alumis Inc. (15.02%), Tarsus Pharmaceuticals, Inc. (12.62%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($80.71 billion), Invesco QQQ ($47.96 billion), iShares Russell 2000 ETF ($22.13 billion), Western Digital Corporation ($14.35 billion), Sandisk Corporation ($12.86 billion), Salesforce Inc. ($10.89 billion), Nebius Group N.V. ($9.92 billion), SPDR S&P Biotech ETF ($9.72 billion), Lumentum Holdings Inc. ($8.89 billion), and iShares 20+ Year Treasury Bond ETF ($8.18 billion). View all of the most shorted stocks.

Short selling CGEM is an investing strategy that aims to generate trading profit from Cullinan Therapeutics as its price is falling. CGEM shares are trading up $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Cullinan Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CGEM, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CGEM, twice per month. The most recent reporting period available is May, 15 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like CGEM:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NASDAQ:CGEM) was last updated on 5/28/2026 by MarketBeat.com Staff.
From Our Partners
How to claim a stake in SpaceX before the June 12 IPO
SpaceX is expected to go public on June 12 - and for the first time, everyday investors may have a way in befo...
Brownstone Research | Sponsoredtc pixel
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel
The SpaceX hype is real. So is what happens after.
SpaceX just filed for what could be a $2 trillion IPO, with the roadshow starting in June. History shows that ...
Americas Gold Company | Sponsoredtc pixel
Massive Data Leak Exposes 512,000-Line Code That Could Change Society Forever
"You won't believe what I discovered at 4 World Trade Center" When our financial media correspondent travel...
Chaikin Analytics | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
A letter from Shannon Stansberry
Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...
Porter & Company | Sponsoredtc pixel
Goldman Sachs just told you what to buy (most people missed it)
Goldman Sachs just revealed that 40% of AI data centers will be crippled by electricity shortages by 2027 - no...
Behind the Markets | Sponsoredtc pixel
A 25,000% opportunity
Angel investor Jason Calacanis - who made a fortune on an early Uber stake - says Elon Musk's latest project c...
The Oxford Club | Sponsoredtc pixel